Related Experiment Video
Updated: Feb 7, 2026

Use of a High-throughput In Vitro Microfluidic System to Develop Oral Multi-species Biofilms
Published on: December 1, 2014
Introduction to the OrBiTo decision tree to select the most appropriate in vitro methodology for release testing of
C J Andreas1, J Rosenberger1, J Butler2
1Institute of Pharmaceutical Technology, Goethe University Frankfurt, Frankfurt am Main, Germany.
The OrBiTo WP2 Decision Tree aids researchers in selecting optimal in vitro methods for drug formulation development. This tool helps predict drug absorption and accelerates the formulation process for pharmaceutical sciences.
Area of Science:
- Pharmaceutical Sciences
- Drug Development
- Biopharmaceutics
Background:
- The EU research initiative OrBiTo (oral biopharmaceutics tools) aimed to enhance drug absorption prediction and accelerate formulation development.
- Work Package 2 (WP2) of the OrBiTo project specifically focused on the characterization of drug formulations.
- Existing methods for optimizing oral drug formulation and development require efficient tools for selecting appropriate in vitro assays.
Purpose of the Study:
- To introduce the OrBiTo WP2 Decision Tree, a novel tool designed to guide researchers in choosing suitable in vitro methods.
- To assist in optimizing oral formulation design and development by providing a structured approach to method selection.
- To facilitate the prediction of drug absorption in humans and streamline the formulation development process.
Main Methods:
- The OrBiTo WP2 Decision Tree employs a four-stage process for guiding investigators.
- Stage 1: Selection of the formulation type.
- Stage 2: Identification of preferred or available equipment (compendial, modified, noncompendial).
- Stage 3: Evaluation of active pharmaceutical ingredient (API) characteristics.
- Stage 4: Recommendation of appropriate experimental protocols.
Main Results:
- The Decision Tree provides a systematic framework for selecting in vitro methods relevant to oral drug formulation.
- It integrates formulation type, equipment availability, and API properties to recommend specific experimental protocols.
- A 'living' document of the Decision Tree is available for community use and feedback.
Conclusions:
- The OrBiTo WP2 Decision Tree serves as a valuable resource for the pharmaceutical sciences community.
- Its application can improve the efficiency and effectiveness of oral drug formulation development and characterization.
- The project invites collaboration for the continuous improvement and expansion of the Decision Tree tool.
Related Concept Videos
In Vitro Drug Release Testing: Overview, Development and Validation
Dosage Regimen: Multiple Oral Dosage
The Tree of Life - Bacteria, Archaea, Eukaryotes
Dosage Compensation
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Structures of Solids

